To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment

计划入组 600 人 · 首次发布于 2026 年 7 月 6 日

HP011-101, HP828-101, and Standard Care for Pressure Ulcers

首次发布于 2011 年 1 月 10 日

ATX-101 Abdominoplasty

计划入组 14 人 · 首次发布于 2009 年 2 月 4 日

STEL-101

OTOV-101

PG-101

浙江章光101有限公司

EUN JUNG KIM

United States

北京章光101药业有限公司

Expedition Therapeutics Raises $115M Series B as DPP1 Inhibitor EXPD-101 Enters Phase 2 COPD Trial

Expedition Therapeutics Secures $165 Million Series A to Advance First-in-Class DPP1 Inhibitor for COPD

Expedition Therapeutics Raises $115M Series B to Advance First Global Phase 2 Trial of DPP1 Inhibitor in COPD